Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,599.00
Bid: 1,594.50
Ask: 1,595.50
Change: -19.00 (-1.17%)
Spread: 1.00 (0.063%)
Open: 1,608.00
High: 1,615.00
Low: 1,575.00
Prev. Close: 1,618.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday newspaper round-up: Ireland, General Motors, GlaxoSmithKline

Thu, 18th Nov 2010 06:31

The Irish Government finally signalled yesterday that it may bow to international pressure and accept a multibillion-pound bailout, amid divisions in the Commons over whether Britain should contribute. While the details of any package may be several days away, there were growing signs that Britain could play a prominent role in any rescue, the Times reports.According to the Telegraph, a squad of inspectors from the EU and the International Monetary Fund will arrive in Dublin on Thursday to go through the books of the Irish banking system and prepare the way for a likely rescue of at least €80bn (£68bn). Olli Rehn, Europe's economics commissioner, said Ireland is not strong enough to back-stop a banking system that has been shut out of capital markets and suffered a haemorrhage of bank deposits.With the unemployment rate still above 13% and remaining high, many with a bankable trade are now considering taking the drastic option of leaving Ireland in search of work, the Independent adds. The government expects as many as 100,000 people to leave over the next four years.General Motors could raise almost $23bn (£14.5m) in the largest flotation in history when it rejoins the public market today. The carmaker said yesterday that it had increased the number of common shares it would sell from 365m to 478m, 412 million of which would come from the US Government. GlaxoSmithKline is close to securing formal US approval for the first new drug in 50 years to treat the complex autoimmune disease lupus, after experts recommended the release of the treatment despite broad safety concerns. The drug, known as Benlysta, is one of the most important new drugs in Glaxo's pipeline, says the Guardian. Britain's electricity market is braced for its biggest shake-up since privatisation as the Government prepares to unveil a package of measures designed to shore up £200 billion worth of investment in greener sources of energy over the next decade. The Times has learnt that David Cameron discussed the proposed changes on Monday with officials from the Treasury, the Department for Energy and Climate Change and Chris Huhne, the Energy Secretary.Business investment is bouncing back, according to the Bank of England, offering proof that the Government's private-sector led recovery is starting to bear fruit, the Telegraph reports. The Bank's November business conditions survey found that "investment plans over the next twelve months were more positive than outturns had been over the past twelve months", and that many companies "were gradually increasing capital spending". A multi-million pound investigation by the Office of Fair Trading into allegations of price fixing in the supermarket sector has been pulled in the latest blow to the embattled regulator, the Daily Telegraph says. The investigation has been quietly shelved after the Office of Fair Trading (OFT) failed to find sufficient evidence of wrongdoing. The OFT raided a number of supermarkets and consumer goods companies in April 2008 after receiving information suggesting possible price collusion. Dawn raids were launched at Tesco, Asda, Sainsbury's and Morrisons.Asda's plans to leapfrog Tesco to become the UK's biggest general merchandise retailer appear to be stalling after it admitted that it is set to open only two new Asda Living non-food stores in 2011. After unveiling just two shops this year, the Walmart-owned supermarket chain now has 25 Asda Living stores, which sell products such as its George clothing brand and homewares, the Independent says.BP's board will tighten its oversight of the company's day-to-day operations in the wake of the Gulf of Mexico oil spill, its chairman has said in his first big interview since the accident. Carl-Henric Svanberg, app­oint­ed chairman in January, said he did not consider resigning following the oil spill in April, in spite of criticism from some investors for not taking a more public role at the height of the crisis, the FT reports.
More News
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.